EU OKs AstraZeneca diabetes drug

|About: AstraZeneca Group plc (AZN)|By:, SA News Editor

European regulators have approved AstraZeneca's (AZN) Xigduo treatment for Type 2 diabetes.

The authorization is the first for a drug that combines an SGLT2 inhibitor, which cuts the reabsorption of excess glucose, and metformin, a standard therapy. (PR)